Any feedback?
Literature summary for 1.6.2.2 extracted from
- Characterization of the purified NADH-cytochrome b5 reductase of human erythrocytes as a FAD-containing enzyme (1980), J. Biol. Chem., 255, 2454-2456.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| Acrynol | 0.1 mM, 88% inhibition | Homo sapiens |  |
| Atebrin | 0.1 mM, 44% inhibition | Homo sapiens | |
| Proflavin | 0.1 mM, 98% inhibition | Homo sapiens | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
- |
Homo sapiens |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| erythrocyte | soluble form | Homo sapiens | - |
Cofactor
| Cofactor | Comment | Organism | Structure |
|---|---|---|---|
| FAD | - |
Homo sapiens | |
| NADH | - |
Homo sapiens | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
